The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Dysfunction of phospholipase Cγ in immune disorders and cancer
Abstract
The surge in genetic and genomic investigations over the past 5 years has resulted in many discoveries of causative variants relevant to disease pathophysiology. Although phospholipase C (PLC) enzymes have long been recognized as important components in intracellular signal transmission, it is only recently that this approach highlighted their role in disease development through gain-of-function mutations. In this review we describe the new findings that link the PLCγ family to immune disorders and cancer, and illustrate further efforts to elucidate the molecular mechanisms that underpin their dysfunction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The protective variant P522R is certainly located within a region of the enzyme that has a regulatory function (Fig. 4d, [7])”
From Alzheimer’s disease phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorph (2019) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although not covered in this review, the importance of aberrant functions of different PLCs and PI3Ks in disease development is well established and continues to expand [11,62,67,72,134–138].”
From Phosphatidylinositol(4,5)bisphosphate: diverse functions at the plasma membrane (2020) · cites this paper as [137]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A main effector downstream of TREM2, PLCγ2 is an intracellular lipase recruited to the membrane upon activation [3, 4].”
From TREM2/PLCγ2 signalling in immune cells: function, structural insight, and potential therapeutic modulation (2021) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the majority of hypermorphic variants (S707Y, Y495C, D993G) have been identified in the context of APLAID disorders, and in some mouse models with autoinflammatory phenotypes [3, 109, 110]”
From TREM2/PLCγ2 signalling in immune cells: function, structural insight, and potential therapeutic modulation (2021) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“PLCγ2 is present in circulating monocytes, platelets and B-cells, amongst other immune cells (see sections above, [3, 130])”
From TREM2/PLCγ2 signalling in immune cells: function, structural insight, and potential therapeutic modulation (2021) · cites this paper as [3]
Experimental — accuracy not yet measured
The cited source says what the claim attributes to it.
In the citing paper
“PLCγ2 shares high structural and mechanistic overlap with the other member of the PLCγ family, PLCγ1 [7].”
From Alzheimer’s disease phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorph (2019) · cites this paper as [7]
The cited source says what the claim attributes to it.
In the citing paper
“Other mutations in PLCG2 that lead to immune dysfunction are known to be activating [7].”
From Alzheimer’s disease phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorph (2019) · cites this paper as [7]
The cited source says what the claim attributes to it.
In the citing paper
“While PLCγ1 is ubiquitously expressed and regulates growth factor signalling in a variety of cell types, expression of PLCγ2 is largely restricted to hematopoietic cells, and regulates specific responses downstream of several immune receptors8.”
From PLCγ2 regulates TREM2 signalling and integrin-mediated adhesion and migration of human iPSC-derived macrophages (2021) · cites this paper as [8]
The cited source says what the claim attributes to it.
In the citing paper
“with variants of these genes known to cause diseases such as Nasu-Hakola disease (TREM2) [22], and PLCγ2-associated antibody deficiency (PLAID), or autoinflammation and PLAID (APLAID) [3].”
From TREM2/PLCγ2 signalling in immune cells: function, structural insight, and potential therapeutic modulation (2021) · cites this paper as [3]
The cited source says what the claim attributes to it.
In the citing paper
“PLAID-affected individuals have reduced PLCγ2-mediated signal transduction at physiological temperatures, despite constitutive enzyme activation [3, 113]”
From TREM2/PLCγ2 signalling in immune cells: function, structural insight, and potential therapeutic modulation (2021) · cites this paper as [3]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi
Raamsdonk, C. D. V., Bezrookove, V., Green, G., Bauer, J. M., Gaugler, L., O’Brien, J. M., Simpson, E. M., Barsh, G. S., & Bastian, B. C. (2008) · Nature · doi:10.1038/nature07586 · Cited by 1,648
Phosphoinositides: Tiny Lipids With Giant Impact on Cell Regulation
Balla, T. (2013) · Physiological Reviews · doi:10.1152/physrev.00028.2012 · Cited by 1,638
Regulation of Phosphoinositide-Specific Phospholipase C
Rhee, S. G. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.281 · Cited by 1,628
Resistance Mechanisms for the Bruton's Tyrosine Kinase Inhibitor Ibrutinib
Woyach, J. A., Furman, R. R., Liu, T.-M., Ozer, H. G., Zapatka, M., Ruppert, A. S., Xue, L., Li, D. H.-H., Steggerda, S. M., Versele, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1400029 · Cited by 1,275
Initial impact of the sequencing of the human genome
Lander, E. S. (2011) · Nature · doi:10.1038/nature09792 · Cited by 1,044
Structure, Function, and Control of Phosphoinositide-Specific Phospholipase C
Rebecchi, M. J., & Pentyala, S. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.4.1291 · Cited by 1,000
Kim, H.-K., Kim, J., Zilberstein, A., Margolis, B. L., Kim, J. G., Schlessinger, J., & Rhee, S. G. (1991) · Cell · doi:10.1016/0092-8674(91)90461-7 · Cited by 570
Kadamur, G., & Ross, E. M. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183750 · Cited by 529
Multiple roles of phosphoinositide-specific phospholipase C isozymes
Suh, P.-G., Park, J.-I., Manzoli, L., Cocco, L., Peak, J. C., Katan, M., Fukami, K., Kataoka, T., Yun, S.-U., & Ryu, S.-H. (2008) · BMB Reports · doi:10.5483/bmbrep.2008.41.6.415 · Cited by 501
Self-citationCold Urticaria, Immunodeficiency, and Autoimmunity Related to PLCG2 Deletions
Ombrello, M. J., Remmers, E. F., Sun, G., Freeman, A. F., Datta, S., Torabi-Parizi, P., Subramanian, N., Bunney, T. D., Baxendale, R. W., Martins, M. S., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1102140 · Cited by 425
Self-citation
Cited by
Sorted by citations
Comprehensive review of targeted therapy for colorectal cancer
Xie, Y.-H., Chen, Y.-X., & Fang, J.-Y. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0116-z · Cited by 1,687
Integrated molecular analysis of adult T cell leukemia/lymphoma
Kataoka, K., Nagata, Y., Kitanaka, A., Shiraishi, Y., Shimamura, T., Yasunaga, J., Totoki, Y., Chiba, K., Sato‐Otsubo, A., Nagae, G., et al. (2015) · Nature Genetics · doi:10.1038/ng.3415 · Cited by 844
The Inositol Trisphosphate/Calcium Signaling Pathway in Health and Disease
Berridge, M. J. (2016) · Physiological Reviews · doi:10.1152/physrev.00006.2016 · Cited by 779
Neutrophils as emerging therapeutic targets
Németh, T., Sperandio, M., & Mócsai, A. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0054-z · Cited by 676
Lipid metabolism in cancer progression and therapeutic strategies
Fu, Y., Zou, T., Shen, X., Nelson, P. J., Li, J., Wu, C., Yang, J., Zheng, Y., Bruns, C. J., Zhao, Y., et al. (2020) · MedComm · doi:10.1002/mco2.27 · Cited by 428
Protein kinase D at the Golgi controls NLRP3 inflammasome activation
Zhang, Z., Mészáros, G., He, W., Xu, Y., Magliarelli, H. D. F., Mailly, L., Mihlan, M., Liu, Y., Gámez, M. P., Goginashvili, A., et al. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20162040 · Cited by 296
Phosphatidylinositol(4,5)bisphosphate: diverse functions at the plasma membrane
Katan, M., & Cockcroft, S. (2020) · Essays in Biochemistry · doi:10.1042/ebc20200041 · Cited by 176
Self-citationAlzheimer’s disease phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorph
Magno, L., Lessard, C. B., Martins, M., Lang, V., Cruz, P., Asi, Y., Katan, M., Bilsland, J., Lashley, T., Chakrabarty, P., et al. (2019) · Alzheimer's Research & Therapy · doi:10.1186/s13195-019-0469-0 · Cited by 143
Self-citationProtective genes and pathways in Alzheimer’s disease: moving towards precision interventions
Seto, M., Weiner, R. L., Dumitrescu, L., & Hohman, T. J. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00452-5 · Cited by 135
DESGESCO (Dementia Genetics Spanish Consortium), E. (. D. E. D. B., van der Lee, S. J., biobank), E. (. D. E. D., IFGC (International FTD-Genomics Consortium), I. (. I. P. D. G. C., IPDGC (The International Parkinson Disease Genomics Consortium), Dementia), R.-F. (. A. M. F. I. F.-T., (NBB), N. B. B., The GIFT (Genetic Investigation in Frontotemporal Dementia and Alzheimer’s Disease) Study Group, Conway, O. J., Jansen, I., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02026-8 · Cited by 120
Bill, C. A., & Vines, C. M. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-12457-1_9 · Cited by 128
The role of the immune system in Alzheimer’s disease
Wu, K., Zhang, Y.-R., Huang, Y., Dong, Q., Tan, L., & Yu, J. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101409 · Cited by 119
The role of PLCγ2 in immunological disorders, cancer, and neurodegeneration
Jackson, J. T., Mulazzani, E., Nutt, S. L., & Masters, S. L. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100905 · Cited by 113
“PLCγ2 was first cloned in a functional form, including the promoter region, in the hematopoietic Raji cell line (4).”
BackgroundCandidate driver genes involved in genome maintenance and DNA repair in Sézary syndrome
Woollard, W. J., Pullabhatla, V., Lorenc, A., Patel, V. M., Butler, R. M., Bayega, A., Begum, N., Bakr, F. S., Dedhia, K., Fisher, J. N. B., et al. (2016) · Blood · doi:10.1182/blood-2016-02-699843 · Cited by 108
Hajicek, N., Keith, N. C., Siraliev-Perez, E., Temple, B. R., Huang, W., Zhang, Q., Harden, T. K., & Sondek, J. (2019) · eLife · doi:10.7554/elife.51700 · Cited by 89
Phosphoinositide-Dependent Signaling in Cancer: A Focus on Phospholipase C Isozymes
Obeng, E. O., Rusciano, I., Marvi, M. V., Fazio, A., Ratti, S., Follo, M. Y., Xian, J., Manzoli, L., Billi, A. M., Mongiorgi, S., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072581 · Cited by 89
Novel PLCG2 Mutation in a Patient With APLAID and Cutis Laxa
Neves, J. F., Doffinger, R., Barcena-Morales, G., Martins, C., Papapietro, O., Plagnol, V., Curtis, J., Martins, M., Kumararatne, D., Cordeiro, A. I., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02863 · Cited by 79
Self-citationThe Role of Phospholipase C Signaling in Macrophage-Mediated Inflammatory Response
Zhu, L., Jones, C., & Zhang, G. (2018) · Journal of Immunology Research · doi:10.1155/2018/5201759 · Cited by 77
Jones, D., Woyach, J. A., Zhao, W., Caruthers, S., Tu, H., Coleman, J., Byrd, J. C., Johnson, A. J., & Lozanski, G. (2017) · Leukemia · doi:10.1038/leu.2017.110 · Cited by 71
Campomanes, P., Zoni, V., & Vanni, S. (2019) · Communications Chemistry · doi:10.1038/s42004-019-0175-7 · Cited by 67
Magno, L., Bunney, T. D., Mead, E., Svensson, F., & Bictash, M. N. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00436-5 · Cited by 64
Self-citationHajicek, N., & Sondek, J. (2019) · Worldwide Protein Data Bank · doi:10.2210/pdb6pbc/pdb · Cited by 58
Martín-Nalda, A., Fortuny, C., Rey, L., Bunney, T. D., Alsina, L., Esteve-Solé, A., Bull, D., Anton, M. C., Basagaña, M., Casals, F., et al. (2020) · Journal of Clinical Immunology · doi:10.1007/s10875-020-00794-7 · Cited by 56
Self-citationClaes, C., England, W. E., Danhash, E. P., Kiani Shabestari, S., Jairaman, A., Chadarevian, J. P., Hasselmann, J., Tsai, A. P., Coburn, M. A., Sanchez, J., et al. (2022) · Alzheimer's & Dementia · doi:10.1002/alz.12577 · Cited by 52
Cognitively healthy centenarians are genetically protected against Alzheimer's disease
Tesi, N., van der Lee, S., Hulsman, M., van Schoor, N. M., Huisman, M., Pijnenburg, Y., van der Flier, W. M., Reinders, M., & Holstege, H. (2024) · Alzheimer's & Dementia · doi:10.1002/alz.13810 · Cited by 52
Mandal, S., Bandyopadhyay, S., Tyagi, K., & Roy, A. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188619 · Cited by 51
Emerging roles of PLCγ1 in endothelial biology
Chen, D., & Simons, M. (2021) · Science Signaling · doi:10.1126/scisignal.abc6612 · Cited by 48
Liu, Y., Bunney, T. D., Khosa, S., Macé, K., Beckenbauer, K., Askwith, T., Maslen, S., Stubbs, C., de Oliveira, T. M., Sader, K., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2019.102607 · Cited by 42
Self-citationCXCL8 and the peritoneal metastasis of ovarian and gastric cancer
Fu, X., Wang, Q., Du, H., & Hao, H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1159061 · Cited by 43
Maguire, E., Menzies, G. E., Phillips, T., Sasner, M., Williams, H. M., Czubala, M. A., Evans, N., Cope, E. L., Sims, R., Howell, G. R., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2020105603 · Cited by 41
Gao, C., Shen, X., Tan, Y., & Chen, S. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02580-1 · Cited by 48
A Systematic Compilation of Human SH3 Domains: A Versatile Superfamily in Cellular Signaling
Mehrabipour, M., Jasemi, N. S. K., Dvorský, R., & Ahmadian, M. R. (2023) · Cells · doi:10.3390/cells12162054 · Cited by 40
Regulation and physiological functions of mammalian phospholipase C
Nakamura, Y., & Fukami, K. (2017) · Journal of Biochemistry · doi:10.1093/jb/mvw094 · Cited by 122
A gain-of-function variation in PLCG1 causes a new immune dysregulation disease
Tao, P., Han, X., Wang, Q., Wang, S., Zhang, J., Liu, L., Fan, X., Liu, C., Liu, M., Guo, L., et al. (2023) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2023.06.020 · Cited by 38
Obst, J., Hall-Roberts, H. L., Smith, T. B., Kreuzer, M., Magno, L., Di Daniel, E., Davis, J. B., & Mead, E. (2021) · Scientific Reports · doi:10.1038/s41598-021-96144-7 · Cited by 36
Holme, M. N., Rashid, M. H., Thomas, M. R., Barriga, H. M. G., Herpoldt, K., Heenan, R. K., Dreiss, C. A., Bañuelos, J. L., Xie, H., Yarovsky, I., et al. (2018) · ACS Central Science · doi:10.1021/acscentsci.8b00286 · Cited by 37
Kim, K., Kim, Y., Rivard, C. J., Kim, D., & Park, K.-S. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-1453 · Cited by 35
Wist, M., Meier, L., Gutman, O., Haas, J., Endres, S., Zhou, Y., Rösler, R., Wiese, S., Stilgenbauer, S., Hobeika, E., et al. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.011946 · Cited by 34
Patel, V. M., Flanagan, C. E., Martins, M., Jones, C. L., Butler, R. M., Woollard, W. J., Bakr, F. S., Yoxall, A., Begum, N., Katan, M., et al. (2019) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2019.07.693 · Cited by 32
Self-citationPLCγ1 suppression promotes the adaptation of KRAS-mutant lung adenocarcinomas to hypoxia
Saliakoura, M., Sebastiano, M. R., Pozzato, C., Heidel, F. H., Schnoeder, T. M., Prince, S. S., Bubendorf, L., Pinton, P., Schmid, R. A., Baumgartner, J., et al. (2020) · Nature Cell Biology · doi:10.1038/s41556-020-00592-8 · Cited by 32
Gramolelli, S., Weidner-Glunde, M., Abere, B., Viejo‐Borbolla, A., Bala, K., Rückert, J., Kremmer, E., & Schulz, T. F. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1005105 · Cited by 30
Angiotensin Converting Enzyme Regulates Cell Proliferation and Migration
de Alvarenga, É. C., Fonseca, M. D. C., Carvalho, C. C., Florentino, R. M., França, A., Matias, E., Guimarães, P. B., Batista, C., Freire, V. N., Carmona, A. K., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0165371 · Cited by 31
Biochemistry of Autoinflammatory Diseases: Catalyzing Monogenic Disease
Beck, D. B., & Aksentijevich, I. A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00101 · Cited by 29
Phospholipase Cγ2 regulates endocannabinoid and eicosanoid networks in innate immune cells
Jing, H., Reed, A., Ulanovskaya, O. A., Grigoleit, J.-S., Herbst, D. M., Henry, C. L., Li, H., Barbas, S., Germain, J., Masuda, K., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2112971118 · Cited by 24
Xu, X., & Jin, T. (2015) · Journal of Immunology Research · doi:10.1155/2015/817604 · Cited by 26
Fong, W., Sánchez‐Ferrer, A., Rappolt, M., Boyd, B. J., & Mezzenga, R. (2019) · Langmuir · doi:10.1021/acs.langmuir.9b02288 · Cited by 22
Indole-3-Carbinol and Its Derivatives as Neuroprotective Modulators
Singh, A. A., Yadav, D., Khan, F., & Song, M. (2024) · Brain Sciences · doi:10.3390/brainsci14070674 · Cited by 22
Oncogenic role of phospholipase C‐γ1 in progression of hepatocellular carcinoma
Tang, W., Zhou, Y., Sun, D., Dong, L., Xia, J., & Yang, B. (2019) · Hepatology Research · doi:10.1111/hepr.13309 · Cited by 22
Le Huray, K. I. P., Bunney, T. D., Pinotsis, N., Kalli, A. C., & Katan, M. (2022) · Science Advances · doi:10.1126/sciadv.abp9688 · Cited by 21
Self-citationCoordinated loss of microRNA group causes defenseless signaling in malignant lymphoma
Yamagishi, M., Katano, H., Hishima, T., Shimoyama, T., Ota, Y., Nakano, K., Ishida, T., Okada, S., & Watanabe, T. (2015) · Scientific Reports · doi:10.1038/srep17868 · Cited by 20
Ren, Y., Li, H., Yao, J., Tan, Y., Pan, L., Peng, T., Zhao, L., Zhang, G., Yue, J., Hu, X., et al. (2020) · Journal of Proteomics · doi:10.1016/j.jprot.2020.103691 · Cited by 20
Puig, S., Xue, X., Salisbury, R., Shelton, M. A., Kim, S.-M., Hildebrand, M. A., Glausier, J. R., Freyberg, Z., Tseng, G. C., Yocum, A. K., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02241-6 · Cited by 21
Phosphorylation of PLCγ1 by EphA2 Receptor Tyrosine Kinase Promotes Tumor Growth in Lung Cancer
Song, W., Kim, L. C., Han, W., Hou, Y., Edwards, D. N., Wang, S., Blackwell, T. S., Cheng, F., Brantley‐Sieders, D. M., & Chen, J. (2020) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-20-0075 · Cited by 18
Dynamics of allosteric regulation of the phospholipase C-γ isozymes upon recruitment to membranes
Siraliev-Perez, E., Stariha, J. T., Hoffmann, R. M., Temple, B. R., Zhang, Q., Hajicek, N., Jenkins, M. L., Burke, J. E., & Sondek, J. (2022) · eLife · doi:10.7554/elife.77809 · Cited by 18
Li, K., Ran, B., Wang, Y., Liu, L., & Li, W. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.999061 · Cited by 18
Demin, K. A., Krotova, N. A., Ilyin, N. P., Galstyan, D. S., Kolesnikova, T. O., Strekalova, T. V., de Abreu, M. S., Petersen, E. V., Zabegalov, K. N., & Kalueff, A. V. (2022) · Scientific Reports · doi:10.1038/s41598-022-22688-x · Cited by 19
Yang, Z., Kim, S., Mahajan, S., Zamani, A., & Faccio, R. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.764928 · Cited by 17
Li, Z., Liu, Y., Yi, H., Cai, T., & Wei, Y. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.947747 · Cited by 16
The role of phospholipase Cγ1 in breast cancer and its clinical significance
Emmanouilidi, A., Lattanzio, R., Sala, G., Piantelli, M., & Falasca, M. (2017) · Future Oncology · doi:10.2217/fon-2017-0125 · Cited by 16
Inositide-dependent signaling pathways as new therapeutic targets in myelodysplastic syndromes
Mongiorgi, S., Finelli, C., Yang, Y. R., Clissa, C., McCubrey, J. A., Billi, A. M., Manzoli, L., Suh, P., Cocco, L., & Follo, M. Y. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1125885 · Cited by 15
Easter, M., Garth, J. M., Harris, E. S., Shei, R., Helton, E. S., Wei, Y., Denson, R. S., Zaharias, R. S., Rowe, S. M., Geraghty, P. M., et al. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00317 · Cited by 14
Construction of an Immunogenomic Risk Score for Prognostication in Colon Cancer
Zhang, H., Qin, C., Gan, H., Guo, X., & Zhang, L. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00499 · Cited by 13
Mu, T., Hu, H., Ma, Y., Yang, C., Feng, X., Wang, Y., Liu, J., Yu, B., Zhang, J., & Gu, Y. (2022) · Animal Genetics · doi:10.1111/age.13249 · Cited by 12
Reduced PLCG1 expression is associated with inferior survival for myelodysplastic syndromes
Shiseki, M., Ishii, M., Miyazaki, M., Osanai, S., Wang, Y., Yoshinaga, K., Mori, N., & Tanaka, J. (2019) · Cancer Medicine · doi:10.1002/cam4.2717 · Cited by 12
Prawiro, C., Bunney, T. D., Kampyli, C., Yaguchi, H., Katan, M., & Bangham, C. R. M. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2022.166601 · Cited by 11
Self-citationDynamic Allostery in PLCγ1 and Its Modulation by a Cancer Mutation Revealed by MD Simulation and NMR
Koss, H., Bunney, T. D., Esposito, D., Martins, M., Katan, M., & Driscoll, P. C. (2018) · Biophysical Journal · doi:10.1016/j.bpj.2018.05.031 · Cited by 10
Self-citationTime-resolved FRET reports FGFR1 dimerization and formation of a complex with its effector PLCγ1
Perdios, L., Bunney, T. D., Warren, S. C., Dunsby, C. W., French, P. M. W., Tate, E. W., & Katan, M. (2015) · Advances in Biological Regulation · doi:10.1016/j.jbior.2015.09.002 · Cited by 9
Self-citationGuo, J., Xia, T.-Y., Deng, S.-H., Xue, W., Cui, B., & Liu, Y. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.668888 · Cited by 9
Zazzo, A. D., Tahvildari, M., Florakis, G. J., & Dana, R. (2016) · Cornea · doi:10.1097/ico.0000000000000951 · Cited by 9
Characterisation of molecular mechanisms for PLCγ2 disease-linked variants
Bunney, T. D., Kampyli, C., Gregory, A., & Katan, M. (2024) · Advances in Biological Regulation · doi:10.1016/j.jbior.2024.101053 · Cited by 8
Self-citationShin, Y.-C., Plummer-Medeiros, A. M., Mungenast, A., Choi, H.-W., TenDyke, K., Zhu, X., Shepard, J., Sanders, K., Zhuang, N., Hu, L., et al. (2024) · Science Advances · doi:10.1126/sciadv.adn6037 · Cited by 7
Phospholipase C-γ as a Potential Therapeutic Target for Graves’ Orbitopathy
Roh, T. H., Chae, M. K., Ko, J., Kikkawa, D. O., Jang, S. Y., & Yoon, J. S. (2023) · Endocrinology and Metabolism · doi:10.3803/enm.2023.1780 · Cited by 8
Magnesium and the Immune Response
Schmitz, C., & Perraud, A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802168-2.00026-9 · Cited by 7
Nosbisch, J. L., Bear, J. E., & Haugh, J. M. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.101886 · Cited by 7
Okada, M., Nakagawa-Saito, Y., Mitobe, Y., Sugai, A., Togashi, K., Suzuki, S., & Kitanaka, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158785 · Cited by 7
APLAID complicated with arrhythmogenic dilated cardiomyopathy caused by a novel PLCG2 variant
Wang, T., Wang, X., Teng, Y., Wu, L., Zhu, F. Y., Ma, D., Wang, H., & Liu, X. (2024) · Immunologic Research · doi:10.1007/s12026-024-09455-y · Cited by 7
Fluorogenic XY-69 in Lipid Vesicles for Measuring Activity of Phospholipase C Isozymes
Carr, A. J., Siraliev-Perez, E., Huang, W., Sondek, J., & Zhang, Q. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1142-5_17 · Cited by 7
Tripathi, N., Vetrivel, I., Télétchéa, S., Jean, M., Legembre, P., & Laurent, A. D. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194721 · Cited by 7
Tesi, N., van der Lee, S. J., Hulsman, M., van Schoor, N. M., Huisman, M. A., Pijnenburg, Y. A. L., van der Flier, W. M., Reinders, M. J. T., & Holstege, H. H. (2023) · medRxiv · doi:10.1101/2023.05.16.23290049 · Cited by 8
A PI(4,5)P2‐derived “gasoline engine model” for the sustained B cell receptor activation
Xu, C., Wan, Z., Shaheen, S., Wang, J., Yang, Z., & Liu, W. (2019) · Immunological Reviews · doi:10.1111/imr.12775 · Cited by 6
Perestrelo, R., Petković, M., & Silva, C. L. (2021) · Metabolites · doi:10.3390/metabo11010032 · Cited by 6
Xu, X., Wen, X., Bhimani, S., Moosa, A., Parsons, D., Ha, H., & Jin, T. (2023) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiad043 · Cited by 6
Samarina, N., Ssebyatika, G. L., Tikla, T., Waldmann, J.-Y., Abere, B., Nanna, V., Marasco, M., Carlomagno, T., Krey, T., & Schulz, T. F. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009635 · Cited by 6
T Cell Receptor Pathway Mutations in Mature T Cell Lymphomas
Zhang, Y., Cheng, K., & Choi, J. (2023) · Journal of Immunology · doi:10.4049/jimmunol.2200682 · Cited by 4
Hamdi, M., Al-Matwi, M. A., Elghoul, N., Al-Kuwari, H., Sayed, T. S., Riguene, E., & Nomikos, M. (2025) · Medicina · doi:10.3390/medicina61061054 · Cited by 6
Faecal Proteomics and Functional Analysis of Equine Melanocytic Neoplasm in Grey Horses
Tesena, P., Kingkaw, A., Phaonakrop, N., Roytrakul, S., Limudomporn, P., Vongsangnak, W., & Kovitvadhi, A. (2022) · Veterinary Sciences · doi:10.3390/vetsci9020094 · Cited by 5
Mondejar, R., Pérez, C., Onaindía, A., Martı́nez, N., González‐Rincón, J., Pisonero, H., Vaque, J. P., Cereceda, L., Santibáñez, M., Sánchez‐Beato, M., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177524 · Cited by 5
Chen, X., Zhu, X., Wei, Z., & Lv, Q. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29294 · Cited by 5
Dumková, J., Vaškovicová, N., Kristeková, D., Vrlíková, L., Faruzelová, A., Jedličková, A., Tatíčková, M., Alexa, L., Coufalík, P., Bahelková, M., et al. (2025) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2025.139181 · Cited by 4
Xu, X., Kim, W. S., Lee, A. M., & Jin, T. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1633390 · Cited by 4
Phosphoinositide-specific phospholipase C enzymes: Recent advances in a long journey
Macrae, C., Lalović, D., Bunney, T. D., & Katan, M. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2025.159627 · Cited by 5
Self-citationExposed: The Many and Varied Roles of Phospholipase C γ SH2 Domains
Driscoll, P. C. (2015) · Journal of Molecular Biology · doi:10.1016/j.jmb.2015.06.002 · Cited by 4
Editorial: Microglia and peripheral immune cells in aging and neurodegenerative diseases
Qiu, Y., Shen, X., & Xu, H. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1178496 · Cited by 4
Maguire, E., Menzies, G. E., Phillips, T., Sasner, M., Williams, H. M., Czubala, M. A., Evans, N., Cope, E. L., Sims, R., Howell, G. R., et al. (2020) · doi:10.1101/2020.04.27.059600 · Cited by 4
Puig, S., Xue, X., Salisbury, R. B., Shelton, M. A., Kim, S.-M., Hildebrand, M. A., Glausier, J. R., Freyberg, Z., Tseng, G. C., Yocum, A. K., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.07.536056 · Cited by 3
Visvanathan, R., Utsuki, T., Beck, D. E., Clayton, B., Lendy, E. K., Sun, K.-L., Liu, Y., Hering, K. W., Mesecar, A. D., Zhang, Z., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0299541 · Cited by 2
Resveratrol alleviates stress-associated bursal injury in chickens: a transcriptomic analysis
Laghari, F., Zhang, H., He, C., Gong, H., Zhang, J., Chang, Q., Bao, J., & Zhang, R. (2025) · British Poultry Science · doi:10.1080/00071668.2025.2512376 · Cited by 2
Chen, X., Zhu, X., Wei, Z., & Lv, Q. (2020) · Cytology and Genetics · doi:10.3103/s009545272006002x · Cited by 2
Biochemical mechanisms in the regulation of phospholipases
Adefegha, S. A., Molehin, O. R., & Adeleke, O. V. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-15313-6.00006-5 · Cited by 2
A case report of autoinflammation and PLCy2-associated antibody deficiency and immune dysregulation
Leonteva, M. E., Bogdanova, D. V., Moiseeva, A. A., Бурлаков, В. И., Нестеренко, З. А., Merkushov, A. Y., Kan, N. Y., Khoreva, А. L., Rodina, Y. A., Shvets, O. A., et al. (2022) · Pediatric Hematology/Oncology and Immunopathology · doi:10.24287/1726-1708-2022-21-4-163-168 · Cited by 1
Metadata
- Authors
- Koss, H., Bunney, T. D., Behjati, S., & Katan, M.
- Affiliations
- Institute of Structural and Molecular Biology (GB)
- Wellcome Sanger Institute (GB)
- Corresponding author
- Bunney, Tom D.
- Katan, Matilda
- Venue
- Trends in Biochemical Sciences
- Publisher
- Elsevier BV
- Published
- 2014-12
- Volume
- 39
- Issue
- 12
- Pages
- 603-611
- ISSN
- 0968-0004 (ISSN-L)
- OpenAlex
- W2090368019
- Cited by
- 115
- References
- 57
- Citations by year
- 2026: 1 · 2025: 7 · 2024: 6 · 2023: 17 · 2022: 14 · 2021: 13 · 2020: 20 · 2019: 12 · 2018: 5 · 2017: 6 · 2016: 6 · 2015: 8
- FWCI
- 0.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Trends in Biochemical Sciences (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Wellcome Trust
- Cancer Research UK (16567)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
- Keywords
- phospholipase C-gamma, immune disorders, cancer, gain-of-function mutations, intracellular signaling, disease pathophysiology, genetic variants
- MeSH terms
- Animals, Diglycerides, Humans, Immune System Diseases, Models, Biological, Models, Molecular, Mutation, Neoplasms, Protein Conformation, Second Messenger Systems, Inositol 1,4,5-Trisphosphate, Phospholipase C gamma
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
